A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants
Condition: Non-alcoholic Steatohepatitis Interventions: Drug: Cotadutide; Drug: Cotadutide-placebo; Drug: Moxifloxacin; Drug: Moxifloxacin-placebo Sponsor: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2022 Category: Research Source Type: clinical trials